Literature DB >> 24805229

Impact of primary care provider knowledge, attitudes, and beliefs about cancer clinical trials: implications for referral, education and advocacy.

Margo Michaels1, Thomas A D'Agostino, Natasha Blakeney, Elisa S Weiss, Maria C Binz-Scharf, Mitch Golant, Carma L Bylund.   

Abstract

Primary Care Providers (PCPs) can be instrumental in helping to prepare patients for referral to cancer treatment. It has been suggested that PCPs can have an important impact on priming patients about the possibility of receiving care within a cancer treatment clinical trial (CCT). However, little is understood about how to effectively engage primary care providers in educating patients about trials. Data were collected as part of two qualitative research projects about primary care providers' role in referral to treatment and to CCTs. Participants were 27 PCPs who agreed to take part in qualitative face-to-face or telephone interviews and serve predominantly underserved, minority populations. Interviews identified a number of factors influencing referral to oncologists, including patients' insurance coverage, location and proximity to treatment facilities, and the strength of ongoing relationships with and/or previous experience with a specialist. PCPs overwhelmingly expressed disinterest in discussing any treatment options, including CCTs. Misconceptions about quality of care received through trials were also common, presenting a deterrent to discussion. PCPs need targeted, evidence-based educational interventions to appropriately address their concerns about cancer clinical trials, enhance provider communication skills, and alter patient referral behavior. Steps must also be taken to strengthen communication between oncologists and referring PCPs.

Entities:  

Mesh:

Year:  2015        PMID: 24805229      PMCID: PMC5417332          DOI: 10.1007/s13187-014-0662-6

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  15 in total

1.  To refer or not to refer: Factors that affect primary care provider referral of patients with cancer to clinical treatment trials.

Authors:  Paula R Sherwood; Barbara A Given; Aaron Scholnik; Charles W Given
Journal:  J Cancer Educ       Date:  2004       Impact factor: 2.037

Review 2.  Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials.

Authors:  J G Ford; M W Howerton; S Bolen; T L Gary; G Y Lai; J Tilburt; M C Gibbons; C Baffi; R F Wilson; C J Feuerstein; P Tanpitukpongse; N R Powe; E B Bass
Journal:  Evid Rep Technol Assess (Summ)       Date:  2005-06

Review 3.  Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review.

Authors:  Jean G Ford; Mollie W Howerton; Gabriel Y Lai; Tiffany L Gary; Shari Bolen; M Chris Gibbons; Jon Tilburt; Charles Baffi; Teerath Peter Tanpitukpongse; Renee F Wilson; Neil R Powe; Eric B Bass
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

4.  Primary care physicians' attitudes, knowledge, and practices related to cancer clinical trials.

Authors:  K Crosson; E Eisner; C Brown; J Ter Maat
Journal:  J Cancer Educ       Date:  2001       Impact factor: 2.037

5.  Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center.

Authors:  Michael S Simon; Wei Du; Lawrence Flaherty; Philip A Philip; Patricia Lorusso; Cheryl Miree; Daryn Smith; Diane R Brown
Journal:  J Clin Oncol       Date:  2004-04-13       Impact factor: 44.544

6.  Clinical research and the physician-patient relationship.

Authors:  Donna T Chen; Franklin G Miller; Donald L Rosenstein
Journal:  Ann Intern Med       Date:  2003-04-15       Impact factor: 25.391

7.  Influence of clinical communication on patients' decision making on participation in clinical trials.

Authors:  Terrance L Albrecht; Susan S Eggly; Marci E J Gleason; Felicity W K Harper; Tanina S Foster; Amy M Peterson; Heather Orom; Louis A Penner; John C Ruckdeschel
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544

8.  Participation in cancer clinical trials: race-, sex-, and age-based disparities.

Authors:  Vivek H Murthy; Harlan M Krumholz; Cary P Gross
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

9.  Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.

Authors:  John H Stewart; Alain G Bertoni; Jennifer L Staten; Edward A Levine; Cary P Gross
Journal:  Ann Surg Oncol       Date:  2007-08-08       Impact factor: 5.344

Review 10.  Are racial and ethnic minorities less willing to participate in health research?

Authors:  David Wendler; Raynard Kington; Jennifer Madans; Gretchen Van Wye; Heidi Christ-Schmidt; Laura A Pratt; Otis W Brawley; Cary P Gross; Ezekiel Emanuel
Journal:  PLoS Med       Date:  2005-12-06       Impact factor: 11.069

View more
  9 in total

1.  Primary care physicians' attitudes and beliefs about cancer clinical trials.

Authors:  Carma L Bylund; Elisa S Weiss; Margo Michaels; Shilpa Patel; Thomas A D'Agostino; Emily B Peterson; Maria Christina Binz-Scharf; Natasha Blakeney; M Diane McKee
Journal:  Clin Trials       Date:  2017-07-11       Impact factor: 2.486

2.  Oncology clinical trials and insurance coverage: An update in a tenuous insurance landscape.

Authors:  Samilia Obeng-Gyasi; Sheetal M Kircher; Kelsey P Lipking; Benjamin J Keele; Al B Benson; Lynne I Wagner; Ruth C Carlos
Journal:  Cancer       Date:  2019-06-28       Impact factor: 6.860

3.  Primary physicians' attitudes toward their patients receiving a proposal to participate in a vaccine trial.

Authors:  Maelle Detoc; Camille Touche; Rodolphe Charles; Frédéric Lucht; Amandine Gagneux-Brunon; Elisabeth Botelho-Nevers
Journal:  Hum Vaccin Immunother       Date:  2019-06-26       Impact factor: 3.452

4.  Barriers for cancer clinical trial enrollment: A qualitative study of the perspectives of healthcare providers.

Authors:  Gaurav Kumar; Priyanka Chaudhary; Aiden Quinn; Dejun Su
Journal:  Contemp Clin Trials Commun       Date:  2022-05-28

5.  Patient and family member perspectives on searching for cancer clinical trials: A qualitative interview study.

Authors:  Jennifer L Ridgeway; Gladys B Asiedu; Katherine Carroll; Meaghan Tenney; Aminah Jatoi; Carmen Radecki Breitkopf
Journal:  Patient Educ Couns       Date:  2016-08-22

6.  A mixed-methods examination of communication between oncologists and primary care providers among primary care physicians in underserved communities.

Authors:  Megan Johnson Shen; Maria Binz-Scharf; Tom D'Agostino; Natasha Blakeney; Elisa Weiss; Margo Michaels; Shilpa Patel; M Diane McKee; Carma L Bylund
Journal:  Cancer       Date:  2014-11-06       Impact factor: 6.860

7.  Design and implementation of a massive open online course on enhancing the recruitment of minorities in clinical trials - Faster Together.

Authors:  Sheila V Kusnoor; Victoria Villalta-Gil; Margo Michaels; Yvonne Joosten; Tiffany L Israel; Marcia I Epelbaum; Patricia Lee; Elizabeth T Frakes; Jennifer Cunningham-Erves; Stephanie A Mayers; Sarah C Stallings; Nunzia B Giuse; Paul A Harris; Consuelo H Wilkins
Journal:  BMC Med Res Methodol       Date:  2021-03-05       Impact factor: 4.615

8.  Advancing Inclusive Research: Establishing Collaborative Strategies to Improve Diversity in Clinical Trials.

Authors:  Owen Garrick; Ruben Mesa; Andrea Ferris; Edward S Kim; Edith Mitchell; Otis W Brawley; John Carpten; Keith D Carter; Joseph Coney; Robert Winn; Stephanie Monroe; Fabian Sandoval; Edith Perez; Mitzi Williams; Evan Grove; Quita Highsmith; Nicole Richie; Susan M Begelman; Asha S Collins; Jamie Freedman; Melissa S Gonzales; Gerren Wilson
Journal:  Ethn Dis       Date:  2022-01-20       Impact factor: 2.006

Review 9.  The impact of income and education on lung cancer screening utilization, eligibility, and outcomes: a narrative review of socioeconomic disparities in lung cancer screening.

Authors:  Samuel Castro; Ernesto Sosa; Vanessa Lozano; Aamna Akhtar; Kyra Love; Jeanette Duffels; Dan J Raz; Jae Y Kim; Virginia Sun; Loretta Erhunmwunsee
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 3.005

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.